Moses F M, Peura D A, Wong R K, Johnson L F
Gastrointest Endosc. 1985 Apr;31(2):61-3. doi: 10.1016/s0016-5107(85)71993-1.
The authors' experience with palliative dilation of 46 consecutive patients evaluated for squamous cell carcinoma of the esophagus was retrospectively reviewed. Thirty-nine of 46 patients (85%) underwent dilation in order to palliate symptoms, enable endoscopy and biopsy, or prepare for placement of an esophageal prosthesis. Thirty-two of the 46 patients (70%) were treated with radiation therapy and seven (15%) underwent placement of an esophageal prosthesis. Thirty-five of the 39 patients dilated (90%) noted improvement in swallowing, allowing resumption of a soft or regular diet. Complications were noted in three of the 39 patients dilated (8%). The authors conclude that peroral dilation is a safe, effective, and probably underutilized method of palliation in patients with squamous cell esophageal carcinoma.
作者回顾性分析了连续46例因食管鳞状细胞癌接受姑息性扩张治疗患者的经验。46例患者中有39例（85%）接受扩张治疗以缓解症状、进行内镜检查和活检或为放置食管假体做准备。46例患者中有32例（70%）接受了放射治疗，7例（15%）接受了食管假体植入。39例接受扩张治疗的患者中有35例（90%）吞咽情况改善，可恢复软食或正常饮食。39例接受扩张治疗的患者中有3例（8%）出现并发症。作者得出结论，经口扩张是食管鳞状细胞癌患者一种安全、有效的姑息治疗方法，可能未得到充分利用。
